Clinical Trials on Aquagenic Pruritus in Poland

Total 41 results

Kiniksa Pharmaceuticals, Ltd.

Completed

Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis

Prurigo Nodularis | Pruritis

United States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, Italy, Korea, Republic of, Poland, Taiwan, United Kingdom
Trevi Therapeutics

Completed

Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus

Pruritus | Uremic Pruritus

United States, Poland, Romania
Cara Therapeutics, Inc.

Completed

CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-2)

Uremic Pruritus

United States, Canada, Czechia, Australia, Germany, Hungary, Korea, Republic of, New Zealand, Poland, Taiwan, United Kingdom
Trevi Therapeutics

Completed

Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis

Pruritus | Prurigo Nodularis | Prurigo | Nodularis Prurigo

United States, Germany, Poland
Cara Therapeutics, Inc.

Completed

CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

Uremic Pruritus

United States, Czechia, Hungary, Poland
Medical University of Lodz

Completed

Non-pharmacological Mitigation of Psoriasis

Depression | Quality of Life | Inflammation | Sleep Disorder | Stress | Psoriasis | Pruritus

Poland
Vyne Therapeutics Inc.

Completed

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis

Psoriasis | Pruritus

United States
Vyne Therapeutics Inc.

Completed

Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin

Pruritus

United States
Maruho Co., Ltd.

Completed

Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis

Atopic Dermatitis

France, Germany, Poland, United Kingdom
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

An Efficacy Study of a New Formulation of Ketoconazole 2% Cream in Patients With Tinea Pedis, Commonly Known as Athlete's Foot

Tinea Pedis

Poland, United Kingdom
DermBiont, Inc.

Active, not recruiting

A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis

Tinea Pedis

United States
Sanofi

Recruiting

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

Pruritus

Poland, China, Spain, Italy, Japan, United States, Canada, France, Germany, Hungary, Korea, Republic of, Argentina
Trevi Therapeutics

Completed

PRISM Study-Pruritus Relief Through Itch Scratch Modulation (PRISM)

Prurigo Nodularis

United States, Austria, France, Germany, Poland
Vyne Therapeutics Inc.

Completed

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis

Pruritus | Prurigo Nodularis

Austria, Germany, Poland
Tinea Pharmaceuticals

Completed

Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot)

Tinea Pedis

United States
Kiniksa Pharmaceuticals, Ltd.

Completed

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

Plaque Psoriasis | Chronic Idiopathic Urticaria | Lichen Planus | Lichen Simplex Chronicus | Chronic Idiopathic Pruritus

United States
Regeneron Pharmaceuticals

Terminated

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Pruritus | Atopic Dermatitis

Poland, Germany, Finland
Merz North America, Inc.

Completed

Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Pedis

Tinea Pedis | Athlete's Foot

United States
Viamet

Completed

A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis

Tinea Pedis

United States
Sienna Biopharmaceuticals

Completed

Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris

Pruritus | Psoriasis Vulgaris

United States
Genzum Life Sciences

Completed

BE Study of Naftifine HCL

Tinea Pedis

United States, Dominican Republic
Vyne Therapeutics Inc.

Completed

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis

Pruritus | Prurigo Nodularis

United States
AmDerma
AmDerma Pharmaceuticals, LLC

Completed

Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis

Tinea Pedis | Athlete's Foot

United States
Cara Therapeutics, Inc.

Recruiting

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica

Pruritus | Notalgia Paresthetica

United States, Poland, Spain, Canada, Germany
Galderma R&D

Completed

To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus (NemoCKDaP)

Chronic Kidney Disease Associated Moderate to Severe Pruritus

Spain, United States, Hungary, Poland
AmDerma
AmDerma Pharmaceuticals, LLC

Completed

Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis

Tinea Pedis | Athlete's Foot

United States
Medicis Global Service Corporation

Completed

Topical Antifungal Treatment for Tinea Pedis

Tinea Pedis

United States, Puerto Rico
Merz North America, Inc.

Completed

Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis (NAFT-600)

Tinea Pedis

United States
Merz North America, Inc.

Completed

Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis (NAFT-600)

Tinea Pedis

United States, Puerto Rico
Vyne Therapeutics Inc.

Terminated

Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)

Psoriasis | Pruritus | Atopic Dermatitis | Prurigo Nodularis

United States, Austria, Germany, Poland
Taisho Pharmaceutical R&D Inc.

Completed

Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)

Atopic Dermatitis

United States
Vyne Therapeutics Inc.

Completed

Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis (ATOMIK)

Pruritus | Atopic Dermatitis

United States
AOBiome LLC
bioRASI, LLC

Completed

B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis

Atopic Dermatitis

United States
Tioga Pharmaceuticals

Completed

Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis

Pruritus | Atopic Dermatitis

United States
GlaxoSmithKline

Completed

Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis

Cholestasis

United States, Australia, France, Spain, Germany, Canada, Japan, United Kingdom, Italy, Poland
Tinea Pharmaceuticals

Completed

Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis

Tinea Pedis | Tinea Cruris | Tinea Corporis

United States, Puerto Rico, El Salvador, Belize, Honduras
GlaxoSmithKline

Active, not recruiting

Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)

Pruritus

United States, France, Spain, Israel, Belgium, Canada, Czechia, Italy, United Kingdom, China, Germany, Mexico, Japan, Brazil, Poland, Russian Federation, Greece, Argentina, Switzerland, Bulgaria
Cara Therapeutics, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Chronic Kidney Diseases | Pruritus

United States
Cara Therapeutics, Inc.

Terminated

CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Chronic Kidney Diseases | Pruritus

United States, Hungary, Australia, Germany, Korea, Republic of, Poland, Argentina, Brazil, Bulgaria, Italy, Mexico, Romania, Spain
Incyte Corporation

Recruiting

Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria

Angioedema | Urticaria | Chronic Idiopathic Urticaria | Pruritis | Chronic Spontaneous Urticaria | Hives

United States, Germany, Poland
Cara Therapeutics, Inc.

Terminated

A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Chronic Kidney Diseases | Pruritus

United States

Clinical Trials on Aquagenic Pruritus in Poland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations